Importance of molecular cell biology investigations in human medicine in the story of the Hutchinson-Gilford progeria syndrome

Ivan Raška

doi:10.2478/v10102-010-0018-y

Abstract

Ranged among laminopathies, Hutchinson-Gilford progeria syndrome is a syndrome that involves premature aging, leading usually to death at the age between 10 to 14 years predominatly due to a myocardial infarction or a stroke. In the lecture I shall overview the importance of molecular cell biology investigations that led to the discovery of the basic mechanism standing behind this rare syndrome. The genetic basis in most cases is a mutation at the nucleotide position 1824 of the lamin A gene. At this position, cytosine is substituted for thymine so that a cryptic splice site within the precursor mRNA for lamin A is generated. This results in a production of abnormal lamin A, termed progerin, its presence in cells having a deleterious dominant effect. Depending on the cell type and tissue, progerin induces a pleiotropy of defects that vary in different tissues. The present endeavour how to challenge this terrible disease will be also mentioned.

References

Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FS. (2003). Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 102(36): 12879-12884.
Search in Google Scholar
Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL, Conneely KN, Qu X, San H, Ganesh SK, Chen X, Avallone H, Kolodgie FD, Virmani R, Nabel EG, Collins FS. (2008). A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci U S A 105(41): 15902-15907.
Search in Google Scholar
Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. (2006). Nuclear Lamins: Laminopathies and Their Role in Premature Ageing. Physiol Rev 86(3): 967-1008.
Search in Google Scholar
Lippincott-Schwartz J, Patterson GH. (2003). Development and Use of Fluorescent Protein Markers in Living Cells. Science 300: 87-91.
Search in Google Scholar
Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B, Brooks BP, Gerber LH, Turner ML, Domingo DL, Hart TC, Graf J, Reynolds JC, Gropman A, Yanovski JA, Gerhard-Herman M, Collins FS, Nabel EG, Cannon RO 3rd, Gahl WA, Introne WJ. (2008). Phenotype and Course of Hutchinson-Gilford Progeria Syndrome. N Engl J Med 358(6): 592-604.
Search in Google Scholar
Scaffidi P, Misteli T. (2005). Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford Progeria Syndrome. Nat Med 11: 440-445.
Search in Google Scholar
Worman HJ, Östlund C, Wang Y. (2010). Diseases of the Nuclear Envelope. Cold Spring Harb Perspect Biol. 2(2): a000760.
Search in Google Scholar

Importance of molecular cell biology investigations in human medicine in the story of the Hutchinson-Gilford progeria syndrome

Abstract

Paradigm

My account